Padmanee Sharma, M.D., Ph.D.

Dr. Sharma is a professor of genitourinary medical oncology and immunology in the division of cancer medicine, the T.C. and Jeanette Hsu endowed chair in cell biology, the scientific director of the immunotherapy platform and the co-director of the Parker Institute for cancer immunotherapy at The University of Texas MD Anderson Cancer Center. She is focused on understanding resistance mechanisms within the immune system that impact anti-tumor responses and for more than a decade, she has been a principal investigator for multiple clinical trials to improve the efficacy of cancer immunotherapies. Dr. Sharma’s work on new pathways to treat prostate cancer implicated for the first time in a human tumor the checkpoint VISTA in inhibiting immune responses. In partnership with Dr. Allison, Dr. Sharma is currently exploring combinations of immunological therapies and targeted drugs in preclinical studies to treat a variety of cancers more effectively.